Vanli Tonyali, N.; Karabay, G.; Arslan, B.; Aktemur, G.; Tokgoz Cakir, B.; Seyhanli, Z.; Demir Çendek, B.; Yilmaz Ergani, S.; Eroglu, H.; Mermi, S.;
et al. Maternal Serum Catestatin Levels in Gestational Diabetes Mellitus: A Potential Biomarker for Risk Assessment and Diagnosis. J. Clin. Med. 2025, 14, 435.
https://doi.org/10.3390/jcm14020435
AMA Style
Vanli Tonyali N, Karabay G, Arslan B, Aktemur G, Tokgoz Cakir B, Seyhanli Z, Demir Çendek B, Yilmaz Ergani S, Eroglu H, Mermi S,
et al. Maternal Serum Catestatin Levels in Gestational Diabetes Mellitus: A Potential Biomarker for Risk Assessment and Diagnosis. Journal of Clinical Medicine. 2025; 14(2):435.
https://doi.org/10.3390/jcm14020435
Chicago/Turabian Style
Vanli Tonyali, Nazan, Gulsan Karabay, Burak Arslan, Gizem Aktemur, Betul Tokgoz Cakir, Zeynep Seyhanli, Busra Demir Çendek, Seval Yilmaz Ergani, Hasan Eroglu, Sumeyye Mermi,
and et al. 2025. "Maternal Serum Catestatin Levels in Gestational Diabetes Mellitus: A Potential Biomarker for Risk Assessment and Diagnosis" Journal of Clinical Medicine 14, no. 2: 435.
https://doi.org/10.3390/jcm14020435
APA Style
Vanli Tonyali, N., Karabay, G., Arslan, B., Aktemur, G., Tokgoz Cakir, B., Seyhanli, Z., Demir Çendek, B., Yilmaz Ergani, S., Eroglu, H., Mermi, S., & Celen, Ş.
(2025). Maternal Serum Catestatin Levels in Gestational Diabetes Mellitus: A Potential Biomarker for Risk Assessment and Diagnosis. Journal of Clinical Medicine, 14(2), 435.
https://doi.org/10.3390/jcm14020435
